Latest Center for Drug Evaluation and Research Stories
With FDA's Approval of the First Biosimilar in the U.S., Groups Urge OMB to Work with FDA to Finalize Critical Naming Policy Supporting Patient Safety WASHINGTON, March 26, 2015 /PRNewswire-USNewswire/
CompassX Group a Health, Biotech and Life Sceience management consulting firm in Orange County, California recently spoke about deploying improvements to the FDA's drug approval process.
Talk Before You Take Campaign Launches in Response to New Research Showing Communication Gaps ROCKVILLE, Md., Jan.
Over a dozen regulators from Europe and USA scheduled to participate Dec. 2-4 BETHESDA, Md., Nov.
AtTask Enterprise Work Cloud Helps FDA Deliver New Generic Drugs to the Market SILICON SLOPES, Utah, Sept.
Dr. Pritpal Tamber, "health explorer" and the Physician Editor of TEDMED 2013, Dr.
NEW YORK, June 27, 2014 /PRNewswire/ -- The U.S.
Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic and consumer health products, was recently invited by
- a slit in a tire to drain away surface water and improve traction.